Naproxen Hasco

Naproxen, the active ingredient in Naproxen Hasco, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for cutaneous use. It treats pain, inflammation and musculoskeletal disorders in adults. GNH USA supplies Naproxen Hasco as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts on inflammatory pathways to relieve pain and swelling in several conditions.

Pain relief: reduces mild to moderate pain such as headache, dental pain, or menstrual cramps. Inflammation reduction: alleviates inflammatory conditions like tendonitis or bursitis. Musculoskeletal disorders: helps manage symptoms of osteoarthritis and rheumatoid arthritis.

Naproxen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Skin irritation at the application site. - Mild rash or itching. - Elevated liver enzymes. - Fluid retention or mild edema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Cardiovascular events such as myocardial infarction or stroke. - Severe renal impairment or acute kidney injury. - Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity with jaundice. - Anaphylactic reactions or severe hypersensitivity.

Before using Naproxen, consider the following safety measures.

Assess gastrointestinal risk: avoid in patients with a history of ulcers or GI bleeding. Evaluate cardiovascular status: use cautiously in those with heart disease or hypertension. Check renal function: monitor kidney parameters in patients with renal impairment. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Monitor concomitant anticoagulant use: increased bleeding risk. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Naproxen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: increased ulcer risk. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: risk of reduced renal perfusion. - Methotrexate: decreased clearance, potential toxicity. - Digoxin: altered plasma concentrations. - Antihypertensive agents: monitor blood pressure response.